ARROWHEAD PHARMACEUTICALS, INC. Income Tax Expense (Benefit) in USD from 2014 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2014 to Q2 2025.
  • Arrowhead Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2025 was -$437K.
  • Arrowhead Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2024 was -$2.77M.
  • Arrowhead Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was $2.78M.
  • Arrowhead Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $3.79M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)

ARROWHEAD PHARMACEUTICALS, INC. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$437K -$437K Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $1.75M* +$1.75M Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-12
Q4 2024 $103K +$3.42M Oct 1, 2024 Dec 31, 2024 10-Q 2025-02-10
Q2 2024 $0 -$742K -100% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12
Q4 2023 -$3.31M* -$3.33M Oct 1, 2023 Dec 31, 2023 10-Q 2025-02-10
Q2 2023 $742K +$742K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $17K +$17K Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-06
Q2 2022 $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $0 Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-06
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q3 2019 $174K $174K +$172K +7150% Jul 1, 2019 Sep 30, 2019 10-K 2021-11-22
Q2 2019 $2.4K $0 $0 Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $2.4K $0 $0 Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $2.4K $0 $0 Oct 1, 2018 Dec 31, 2018 10-Q 2019-02-07
Q3 2018 $2.4K $2.4K Jul 1, 2018 Sep 30, 2018 10-K 2020-11-23
Q2 2018 $0 Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $0 Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-07

ARROWHEAD PHARMACEUTICALS, INC. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$2.77M* -$5.55M Oct 1, 2023 Sep 30, 2024 10-K 2024-11-26
2023 $2.78M* -$1M Oct 1, 2022 Sep 30, 2023 10-K 2024-11-26
2022 $3.79M* +$3.78M Oct 1, 2021 Sep 30, 2022 10-K 2024-11-26
2021 $2K $0 0% Oct 1, 2020 Sep 30, 2021 10-K 2023-11-29
2020 $2K -$172K -98.9% Oct 1, 2019 Sep 30, 2020 10-K 2022-11-28
2019 $174K +$172K +7150% Oct 1, 2018 Sep 30, 2019 10-K 2021-11-22
2018 $2.4K $0 0% Oct 1, 2017 Sep 30, 2018 10-K 2020-11-23
2017 $2.4K $0 0% Oct 1, 2016 Sep 30, 2017 10-K 2019-11-25
2016 $2.4K $0 0% Oct 1, 2015 Sep 30, 2016 10-K 2018-12-11
2015 $2.4K -$2.9K -54.7% Oct 1, 2014 Sep 30, 2015 10-K 2017-12-12
2014 $5.3K Oct 1, 2013 Sep 30, 2014 10-K 2016-12-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.